TransCanna Holdings Inc.
TCNAF
$0.00
$0.000.00%
| Weiss Ratings | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 34.47 | |||
| Price History | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -99.00% | |||
| 2-Year Total Return | -99.98% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 15, 2024 | |||
| 52-Week High Price (Date) | Aug 15, 2024 | |||
| Valuation | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 966.09K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -0.16 | |||
| Earnings Per Share Growth | -29.14% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 78.40M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604-207-5548 | |||
| Address | 2489 Bellevue Avenue West Vancouver, BC V7V 1E1 | |||
| Website | www.transcanna.com | |||
| Country | Canada | |||
| Year Founded | 2017 | |||
| Profitability | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -278.56% | |||
| Profit Margin | -344.37% | |||
| Management Effectiveness | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.43% | |||
| Return on Equity | -- | |||
| Income Statement | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.07M | |||
| Total Revenue (TTM) | 3.07M | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | -1.19M | |||
| EBITDA (TTM) | -7.67M | |||
| EBIT (TTM) | -8.55M | |||
| Net Income (TTM) | -10.56M | |||
| Net Income Avl. to Common (TTM) | -10.56M | |||
| Total Revenue Growth (Q YOY) | -32.21% | |||
| Earnings Growth (Q YOY) | -293.20% | |||
| EPS Diluted (TTM) | -0.16 | |||
| EPS Diluted Growth (Q YOY) | -231.61% | |||
| Balance Sheet | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.09M | |||
| Cash Per Share (Q) | $0.08 | |||
| Total Current Assets (Q) | 6.96M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.58M | |||
| Current Ratio (Q) | 1.134 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 24.86M | |||
| Total Current Liabilities (Q) | 6.13M | |||
| Total Debt (Q) | 20.62M | |||
| Total Liabilities (Q) | 23.28M | |||
| Total Common Equity (Q) | 1.58M | |||
| Cash Flow | TCNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -195.70K | |||
| Cash from Financing (TTM) | 885.50K | |||
| Net Change in Cash (TTM) | -604.10K | |||
| Levered Free Cash Flow (TTM) | -422.20K | |||
| Cash from Operations (TTM) | -1.28M | |||
